Five-year trends for ventilator-associated pneumonia: Correlation between microbiological findings and antimicrobial drug consumption

International Journal of Antimicrobial Agents

Volumn 46, Issue 5, 2015, Pages 518-525

  Fihman, Vincent ^a   Messika, Jonathan ^a,b,c   Hajage, David ^a,c,d,e   Tournier, Véronique ^a   Gaudry, Stéphane ^a,b,c   Magdoud, Fatma ^a   Barnaud, Guilène ^a   Billard Pomares, Typhaine ^a,b,c   Branger, Catherine ^a,b,c   Dreyfuss, Didier ^b,c   Ricard, Jean Damien ^b,c  

^a HÔPITAL LOUIS MOURIER   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Institut National de la Santé et de la Recherche Médicale   (France)

^e INSERM   (France)

Author keywords

Antibiotic resistance; Antibiotic usage; Intensive care unit; Ventilator associated pneumonia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; IMIDAZOLE DERIVATIVE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CORRELATIONAL STUDY; DRUG USE; ENTEROBACTERIACEAE; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; TREND STUDY; VENTILATOR ASSOCIATED PNEUMONIA; ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; COHORT ANALYSIS; DRUG EFFECTS; DRUG UTILIZATION; FEMALE; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; ENTEROBACTERIACEAE; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84947028461     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.07.010     Document Type: Article

References (30)

1. J. Chastre, and J.Y. Fagon Ventilator-associated pneumonia Am J Respir Crit Care Med 165 2002 867 903
2. M. Bekaert, J.F. Timsit, S. Vansteelandt, P. Depuydt, A. Vesin, M. Garrouste-Orgeas, and et al. Attributable mortality of ventilator-associated pneumonia: A reappraisal using causal analysis Am J Respir Crit Care Med 184 2011 1133 1139
3. W.G. Melsen, M.M. Rovers, R.H. Groenwold, D.C. Bergmans, C. Camus, T.T. Bauer, and et al. Attributable mortality of ventilator-associated pneumonia: A meta-analysis of individual patient data from randomised prevention studies Lancet Infect Dis 13 2013 665 671
4. E.L. Kuti, A.A. Patel, and C.I. Coleman Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis J Crit Care 23 2008 91 100
5. M.E. de Kraker, V. Jarlier, J.C. Monen, O.E. Heuer, N. van de Sande, and H. Grundmann The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System Clin Microbiol Infect 19 2013 860 868
6. L.D. Högberg, and O.E. Heuer Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2012 European Centre for Disease Prevention and Control Stockholm, Sweden
7. A. Carbonne, I. Arnaud, S. Maugat, N. Marty, C. Dumartin, X. Bertrand, and et al. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: A 9 year experience J Antimicrob Chemother 68 2013 954 959
8. V. Jarlier, D. Trystram, C. Brun-Buisson, S. Fournier, A. Carbonne, L. Marty, and et al. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program Arch Intern Med 170 2010 552 559
9. R. Cantón, and T.M. Coque The CTX-M β-lactamase pandemic Curr Opin Microbiol 9 2006 466 475
10. H. Gbaguidi-Haore, C. Dumartin, F. L'Heriteau, M. Pefau, D. Hocquet, A.M. Rogues, and et al. Antibiotics involved in the occurrence of antibiotic-resistant bacteria: A nationwide multilevel study suggests differences within antibiotic classes J Antimicrob Chemother 68 2013 461 470
11. N. Goel, C. Wattal, J.K. Oberoi, R. Raveendran, S. Datta, and K.J. Prasad Trend analysis of antimicrobial consumption and development of resistance in non-fermenters in a tertiary care hospital in Delhi, India J Antimicrob Chemother 66 2011 1625 1630
12. C.C. Lai, C.Y. Wang, C.C. Chu, C.K. Tan, C.L. Lu, Y.L. Lee, and et al. Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009 Eur J Clin Microbiol Infect Dis 30 2011 265 271
13. T.C. Horan, M. Andrus, and M.A. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
14. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995 Am J Respir Crit Care Med 153 1996 1711 1725
15. V.S. Baselski, and R.G. Wunderink Bronchoscopic diagnosis of pneumonia Clin Microbiol Rev 7 1994 533 558
16. R. Bonnet, J.D. Cavallo, H. Chardon, C. Chidiac, P. Courvalin, H. Dabernat, and et al. Recommendations of Antibiogram Committee 2011 French Society for Microbiology Paris France 50
17. N.A. Halpern, K.E. Hale, K.A. Sepkowitz, and S.M. Pastores A world without ventilator-associated pneumonia: time to abandon surveillance and deconstruct the bundle Crit Care Med 40 2012 267 270
18. L. Bouadma, E. Deslandes, I. Lolom, B. Le Corre, B. Mourvillier, B. Regnier, and et al. Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit Clin Infect Dis 51 2010 1115 1122
19. M. Hamet, A. Pavon, F. Dalle, A. Pechinot, S. Prin, J.P. Quenot, and et al. Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia Intensive Care Med 38 2012 1272 1279
20. H. Hanberger, D. Arman, H. Gill, V. Jindrak, S. Kalenic, A. Kurcz, and et al. Surveillance of microbial resistance in European intensive care units: A first report from the Care-ICU programme for improved infection control Intensive Care Med 35 2009 91 100
21. A. Sullivan, C. Edlund, and C.E. Nord Effect of antimicrobial agents on the ecological balance of human microflora Lancet Infect Dis 1 2001 101 114
22. J. Carlet The gut is the epicentre of antibiotic resistance Antimicrob Resist Infect Control 1 2012 39
23. C. Jernberg, S. Lofmark, C. Edlund, and J.K. Jansson Long-term impacts of antibiotic exposure on the human intestinal microbiota Microbiology 156 2010 3216 3223
24. K. Kaier, U. Frank, C. Hagist, A. Conrad, and E. Meyer The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum β-lactamase-producing strains: A time-series analysis J Antimicrob Chemother 63 2009 609 614
25. H. Guet-Revillet, A. Le Monnier, N. Breton, P. Descamps, H. Lecuyer, I. Alaabouche, and et al. Environmental contamination with extended-spectrum β-lactamases: is there any difference between Escherichia coli and Klebsiella spp? Am J Infect Control 40 2012 845 848
26. A. Reinhardt, T. Kohler, P. Wood, P. Rohner, J.L. Dumas, B. Ricou, and et al. Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: A longitudinal observation in mechanically ventilated patients Antimicrob Agents Chemother 51 2007 1341 1350
27. T.S. Jacoby, R.S. Kuchenbecker, R.P. Dos Santos, L. Magedanz, P. Guzatto, and L.B. Moreira Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit J Hosp Infect 75 2010 23 27
28. D.M. Livermore, R. Hope, R. Reynolds, R. Blackburn, A.P. Johnson, and N. Woodford Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother 68 2013 2667 2674
29. A. Berrington Antimicrobial prescribing in hospitals: be careful what you measure J Antimicrob Chemother 65 2010 163 168
30. A. Sandiumenge, E. Diaz, A. Rodriguez, L. Vidaur, L. Canadell, M. Olona, and et al. Impact of diversity of antibiotic use on the development of antimicrobial resistance J Antimicrob Chemother 57 2006 1197 1204